Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.32 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.32 |
| ▸ | NTRK1 | P04629 | 9/20 | 0.31 |
| ▸ | HTR2A | P28223 | 4/20 | 0.31 |
| ▸ | HTR2C | P28335 | 3/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30750946 | 0.82 | ALDH1A1 (0.33) | MEN1LMNAKMT2ASMN1; SMN2TP53 | |
| SCHEMBL38910 | 0.82 | ALDH1A1 (0.33) | MEN1LMNAKMT2ASMN1; SMN2TP53 | |
| SCHEMBL7561296 | 0.82 | ALDH1A1 (0.33) | MEN1LMNAKMT2ASMN1; SMN2TP53 | |
| SCHEMBL7585984 | 0.80 | NTRK1 (0.34) | NTRK1TP53MAPT | |
| Desmedipham SCHEMBL7588108 | 0.78 | BRD4 (0.37) | MEN1LMNAKMT2ASMN1; SMN2TP53 | |
| Isoproturon SCHEMBL7587927 | 0.78 | NR3C1 (0.33) | LMNASMN1; SMN2HTR2AHTR2CTP53 | |
| Fluometuron SCHEMBL7581462 | 0.78 | TP53 (0.45) | MEN1LMNAKMT2ASMN1; SMN2HTR2A | |
| Clopyralid SCHEMBL7589112 | 0.77 | RIPK1 (0.34) | MEN1KMT2ASMN1; SMN2TP53MAPT | |
| SCHEMBL7535199 | 0.77 | NTRK1 (0.37) | NTRK1 | |
| Propanil SCHEMBL7585142 | 0.76 | CYP3A4 (0.41) | MEN1LMNAKMT2ASMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | MEN1 4274/4885LMNA 3881/4885KMT2A 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.